CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside

Published:2020-06-07 Issue:1 Volume:192 Page:33-49
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Humbert Olivier¹,Samuelson Clare¹,Kiem Hans‐Peter¹²^ORCID

Affiliation:

1. Fred Hutchinson Cancer Research Center Seattle WAUSA

2. University of Washington School of Medicine Seattle WA USA

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16807

Reference144 articles.

1. Genome Editing: A New Approach to Human Therapeutics

2. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product

3. Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements

4. Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects

5. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR-CAS9-MEDIATED EX VIVO GENE EDITING FOR INHERITED HEMATOLOGICAL DISORDERS: ADVANCEMENTS, CHALLENGES, AND CLINICAL POTENTIAL;International Journal of Pharmacy and Pharmaceutical Sciences;2024-09-01

2. CRISPR technology in human diseases;MedComm;2024-07-29

3. Revolutionizing Sickle Cell Disease Treatment: Unveiling CRISPR and Lentiviral Therapies—Navigating Complexities in Access, Equity, and Global Health Dynamics;Plasmatology;2024-01

4. Exosomes for CRISPR-Cas9 Delivery: The Cutting Edge in Genome Editing;Molecular Biotechnology;2023-11-27

5. CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia;Thalassemia Reports;2023-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3